• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

SB-207499

SRPK2 belongs to a family of serine/arginine (SR) protein-specific kinases (SRPKs)

July 19, 2017 by Katherine Lewis Leave a Comment

SRPK2 belongs to a family of serine/arginine (SR) protein-specific kinases (SRPKs) which phosphorylate SR domain-containing proteins in the nuclear speckles and mediate the pre-mRNA splicing. cells. SR proteins and the related proteins are generally believed to modulate splice site selection via RNA recognition motif (RRM)-mediated binding to exonic splicing enhancers and SR domain-mediated protein-protein and … [Read more…]

Posted in: Blogging Tagged: Rabbit Polyclonal to GPR153., SB-207499

Vascular development is dependent on various growth factors and certain modifiers

June 14, 2017 by Katherine Lewis Leave a Comment

Vascular development is dependent on various growth factors and certain modifiers critical for providing arterial or venous identity interaction with the surrounding stroma and tissues hierarchic network formation and recruitment of pericytes. perfusion. sDll4 similarly induced defective vascular response in tumor implants leading to reduced tumor growth. Interference with Dll4-Notch signaling may be particularly desirable … [Read more…]

Posted in: Blogging Tagged: Rabbit Polyclonal to HSF2., SB-207499

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by